Paper7678656
Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts.
Warrington AE and 2 others. J Neurosci Res, 1993. Cited by 228 papers, by iCite.
Cite this record
ConductScience Library. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. Papers, record 7678656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7678656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myelin Sheath | Major topic |
| Oligodendroglia | Major topic |
| Animals | |
| Brain | |
| Cell Line | |
| Mice | |
| Mice, Neurologic Mutants | |
| Myelin Basic Protein | |
| Rats | |
| Rats, Sprague-Dawley | |
| Reference Values | |
| Stem Cell Transplantation | |
| Stem Cells |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| NS10861 | NINDS NIH HHS | United States | PubMed | PubMed | |
| NS19943 | NINDS NIH HHS | United States | R01NS019943 | PubMed and NIH | NIH RePORTER |
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42934341 | Use of animal models to understand CNS neuroimmunology - guidance from the International Society for Neuroimmunology White Paper Task Force. | Nat Rev Neurol | 2026 | https://conductscience.org/library/papers/42934341 | PubMed |
| 39042298 | A New Acquaintance of Oligodendrocyte Precursor Cells in the Central Nervous System. | Neurosci Bull | 2024 | https://conductscience.org/library/papers/39042298 | PubMed |
| 37084729 | Advancing cell therapy for neurodegenerative diseases. | Cell Stem Cell | 2023 | https://conductscience.org/library/papers/37084729 | PubMed |
| 36924298 | FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/36924298 | PubMed |
| 36204851 | Poly-L-ornithine blocks the inhibitory effects of fibronectin on oligodendrocyte differentiation and promotes myelin repair. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36204851 | PubMed |
| 35805185 | Endogenous Neural Stem Cell Mediated Oligodendrogenesis in the Adult Mammalian Brain. | Cells | 2022 | https://conductscience.org/library/papers/35805185 | PubMed |
| 32413277 | The Median Eminence, A New Oligodendrogenic Niche in the Adult Mouse Brain. | Stem Cell Reports | 2020 | https://conductscience.org/library/papers/32413277 | PubMed |
| 31838017 | Mechanical regulation of oligodendrocyte biology. | Neurosci Lett | 2020 | https://conductscience.org/library/papers/31838017 | PubMed |
| 30487224 | The adult oligodendrocyte can participate in remyelination. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30487224 | PubMed |
| 29859174 | Regenerating Eye Tissues to Preserve and Restore Vision. | Cell Stem Cell | 2018 | https://conductscience.org/library/papers/29859174 | PubMed |
| 28625537 | The Developmental Stage of Adult Human Stem Cell-Derived Retinal Pigment Epithelium Cells Influences Transplant Efficacy for Vision Rescue. | Stem Cell Reports | 2017 | https://conductscience.org/library/papers/28625537 | PubMed |
| 27879672 | Electric Signals Regulate the Directional Migration of Oligodendrocyte Progenitor Cells (OPCs) via β1 Integrin. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27879672 | PubMed |
| 27385127 | Reduced sterol regulatory element-binding protein (SREBP) processing through site-1 protease (S1P) inhibition alters oligodendrocyte differentiation in vitro. | J Neurochem | 2017 | https://conductscience.org/library/papers/27385127 | PubMed |
| 26483609 | Iron Oxide as an MRI Contrast Agent for Cell Tracking. | Magn Reson Insights | 2015 | https://conductscience.org/library/papers/26483609 | PubMed |
| 24961526 | Reprogramming cells for brain repair. | Brain Sci | 2013 | https://conductscience.org/library/papers/24961526 | PubMed |
| 24866099 | Activation of sodium-dependent glutamate transporters regulates the morphological aspects of oligodendrocyte maturation via signaling through calcium/calmodulin-dependent kinase IIβ's actin-binding/-stabilizing domain. | Glia | 2014 | https://conductscience.org/library/papers/24866099 | PubMed |
| 23785157 | CaMKIIβ regulates oligodendrocyte maturation and CNS myelination. | J Neurosci | 2013 | https://conductscience.org/library/papers/23785157 | PubMed |
| 22144101 | Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation. | Glia | 2012 | https://conductscience.org/library/papers/22144101 | PubMed |
| 21918888 | Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury. | Neurotherapeutics | 2011 | https://conductscience.org/library/papers/21918888 | PubMed |
| 21904787 | Cell therapy for multiple sclerosis. | Neurotherapeutics | 2011 | https://conductscience.org/library/papers/21904787 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MBP | 4155 | PubTator's text mining | https://conductscience.org/library/genes/4155 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7678656
GET https://conductscience.org/api/papers/v1/7678656/cited_by?page=2